Searching across hundreds of databases
Subclinical systemic inflammation is a hallmark of obesity and insulin resistance. The results obtained from a number of experimental studies suggest that targeting different components of the inflammatory machinery may result in the improvement of the metabolic phenotype. Unsaturated fatty acids exert antiinflammatory activity through several distinct mechanisms. Here, we tested the capacity of ω3 and ω9 fatty acids, directly from their food matrix, to exert antiinflammatory activity through the G protein-coupled receptor (GPR)120 and GPR40 pathways. GPR120 was activated in liver, skeletal muscle, and adipose tissues, reverting inflammation and insulin resistance in obese mice. Part of this action was also mediated by GPR40 on muscle, as a novel mechanism described. Pair-feeding and immunoneutralization experiments reinforced the pivotal role of GPR120 as a mediator in the response to the nutrients. The improvement in insulin sensitivity in the high-fat substituted diets was associated with a marked reduction in tissue inflammation, decreased macrophage infiltration, and increased IL-10 levels. Furthermore, improved glucose homeostasis was accompanied by the reduced expression of hepatic gluconeogenic enzymes and reduced body mass. Thus, our data indicate that GPR120 and GPR40 play a critical role as mediators of the beneficial effects of dietary unsaturated fatty acids in the context of obesity-induced insulin resistance.
Pubmed ID: 26280128 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets Phospho-GSK-3 (Ser9)
View all literature mentionsThis polyclonal targets GPR120 (N-14)
View all literature mentionsThis monoclonal targets GSK-3alpha/beta
View all literature mentionsThis monoclonal targets GPR120 (H-155)
View all literature mentionsThis polyclonal targets FASN
View all literature mentionsThis monoclonal targets FoxO1 (C29H4) Rabbit mAb
View all literature mentionsThis polyclonal targets IKBKB
View all literature mentionsThis polyclonal targets CHUK, IKBKB
View all literature mentionsThis polyclonal targets IL-1 beta
View all literature mentionsThis polyclonal targets IL-10 (M-18)
View all literature mentionsThis polyclonal targets ITGAM
View all literature mentionsThis polyclonal targets MAP3K7
View all literature mentionsThis monoclonal targets p-IkappaB-alpha (Ser 32)
View all literature mentionsThis polyclonal targets NFKBIA
View all literature mentionsThis polyclonal targets PCK1, PCK2
View all literature mentionsThis polyclonal targets ACTG1, ACTC1, ACTA1, ACTA2, ACTG2, ACTB
View all literature mentionsThis polyclonal targets FFAR1
View all literature mentionsThis monoclonal targets beta-Arrestin 2 (C16D9) Rabbit mAb
View all literature mentionsThis polyclonal targets Rat G6PC
View all literature mentionsThis polyclonal targets MAP3K7IP1
View all literature mentionsThis polyclonal targets Human TNF
View all literature mentionsThis monoclonal targets IL-1beta
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis polyclonal targets Phospho-FoxO1 (Ser256)
View all literature mentionsThis polyclonal targets Phospho-Acetyl-CoA Carboxylase (Ser79)
View all literature mentionsThis monoclonal targets Phospho-Akt (Ser473) (587F11) Mouse mAb
View all literature mentionsThis monoclonal targets p-Tyr (PY20)
View all literature mentionsThis polyclonal targets INSR
View all literature mentionsThis polyclonal targets INSR
View all literature mentionsThis polyclonal targets p-IRS-1 (Tyr 989)
View all literature mentionsThis polyclonal targets AKT1, AKT3
View all literature mentionsThis monoclonal targets JNK1 (F-3)
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
